+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Illumina, Inc.  - logo

Illumina is an American company that specialises in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. Established in 1998, Illumina provide a line of products and services that serve the sequencing, genotyping and gene expression markets. Their technology has significantly reduced the cost of sequencing a human genome and, as a result, they were named the “world’s smartest company” by MIT Technology Review in 2014. Illumina’s clients include research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies.

Nucleic Acid Testing - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Testing - Global Strategic Business Report

  • Report
  • April 2026
  • 283 Pages
  • Global
From
HLA Typing for Transplant - Global Strategic Business Report - Product Thumbnail Image

HLA Typing for Transplant - Global Strategic Business Report

  • Report
  • April 2026
  • 194 Pages
  • Global
From
Oncology Biomarkers Market Report 2026 - Product Thumbnail Image

Oncology Biomarkers Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Neurological Biomarkers Market Report 2026 - Product Thumbnail Image

Neurological Biomarkers Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Oncology NGS Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology NGS Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Rare Disease Diagnostics: Technologies and Global Markets - Product Thumbnail Image

Rare Disease Diagnostics: Technologies and Global Markets

  • Report
  • December 2024
  • 131 Pages
  • Global
From
Loading Indicator